Product Description
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Antibody
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: India
Approved Indications: None
Company: Khon Kaen University
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Menopause
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02503891 |
MA-01 | N/A |
Unknown status |
Osteoarthritis, Hip|Hip Dislocation, Congenital|Spondylitis, Ankylosing|Arthritis, Rheumatoid |
2018-09-01 |
2020-08-05 |
Primary Endpoints|Treatments|Trial Status |
|
NCT02567760 |
HE 571329 | P1 |
Completed |
Menopause |
2016-01-01 |
2019-03-20 |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
01/29/2026 |
News Article |
Reveel Launches "All Modes" -- A Modern Freight Audit & Payment Solution, Delivering Unified Visibility Across Parcel, Air, Ocean, Rail, LTL and FTL |
|
12/11/2025 |
News Article |
Dangbei Lights Up Germany's Christmas Season with Up to 36% Off 4K Laser Projectors |
|
12/11/2025 |
News Article |
Dangbei Launches Christmas Deals on Amazon France — Save Up to €455 on 4K Projectors |
|
12/11/2025 |
News Article |
Dangbei Offers Festive Savings on 4K Projectors in Italy — Christmas Deals Up to 26.7% Off |